Edward John Allera, co-chair of the firm's FDA group, and Matthew Fedowitz, shareholder in the firm's Intellectual Property section, will present Key Business and IP Considerations for Furthering Drug Repurposing Programs for the 9th Annual Repositioning, Repurposing and Rescue Conference.
The presentation will cover the following:
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.